iWriteGigs

Fresh Grad Lands Job as Real Estate Agent With Help from Professional Writers

People go to websites to get the information they desperately need.  They could be looking for an answer to a nagging question.  They might be looking for help in completing an important task.  For recent graduates, they might be looking for ways on how to prepare a comprehensive resume that can capture the attention of the hiring manager

Manush is a recent graduate from a prestigious university in California who is looking for a job opportunity as a real estate agent.  While he already has samples provided by his friends, he still feels something lacking in his resume.  Specifically, the he believes that his professional objective statement lacks focus and clarity. 

Thus, he sought our assistance in improving editing and proofreading his resume. 

In revising his resume, iwritegigs highlighted his soft skills such as his communication skills, ability to negotiate, patience and tactfulness.  In the professional experience part, our team added some skills that are aligned with the position he is applying for.

When he was chosen for the real estate agent position, he sent us this thank you note:

“Kudos to the team for a job well done.  I am sincerely appreciative of the time and effort you gave on my resume.  You did not only help me land the job I had always been dreaming of but you also made me realize how important adding those specific keywords to my resume!  Cheers!

Manush’s story shows the importance of using powerful keywords to his resume in landing the job he wanted.

Mastery EAQ Ch. 26

Navigation   » List of Schools  »  International College of Health Sciences  »  Nursing  »  Nursing 1141- Pharmacology  »  Fall 2022  »  Mastery EAQ Ch. 26

Need help with your exam preparation?

Below are the questions for the exam with the choices of answers:

Question #1
A  The dose will be increased.
B  The dose will be decreased.
C  The medication will be stopped.
D  The dose will be unchanged.
Question #2
A  Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B  Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
C  Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
D  Not a candidate for fondaparinux based on an insufficient creatinine clearance
Question #4
A  Inadequate to evaluate treatment
B  Significantly elevated
C  Within normal limits
D  Significantly decreased
Question #5
A  Administer prescribed vitamin K if bruising is observed.
B  Stop the medication if the systolic blood pressure drops below 110 mm Hg.
C  Assess for dysrhythmias.
D  Monitor liver enzymes.
Question #6
A  Massaging the site after the injection
B  Administering the medication when convenient
C  Checking if the patient’s prescription contains enoxaparin
D  Administering the medication intramuscularly in the vastus lateralis
Question #7
A  “I refrain from drinking coffee and citrus fruit juices daily.”
B  “I take ginkgo supplements for memory enhancement.”
C  “I do not take aspirin for pain relief.”
D  “I eat 1 cup of green leafy vegetables daily.”
Question #8
A  “I never sit with my legs crossed at the knees.”
B  “I avoid tight-fitting stockings or leggings.”
C  “I’ve been on prolonged bed rest.”
D  “I get up and walk around at least once an hour.”
Question #11
A  Heart rate, Hemoglobin, Blood pressure
B  Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
C  Platelet count, Heart rate, Blood pressure
D  Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
Question #12
A  “I will use the medication within 60 days after it is opened.”
B  “I will place the pills in an organizer for easy use.”
C  “I will take the medication with food.”
D  “I will store the bottle in a dry place.”
Question #13
A  Platelet count of 80,000/mm3
B  Diagnosis of diabetes mellitus
C  Loss of 10 pounds
D  Creatinine clearance of 25 mL/min
Question #14
A  The dosage of the warfarin will be decreased by half.
B  The dosage of the warfarin will be increased by half.
C  The dosage of the amiodarone will be increased by half.
D  The dosage of the amiodarone will be decreased by half.
Question #15
A  Continue to administer cimetidine with each dose of warfarin.
B  Instruct the patient to notify the nurse if he or she begins to experience discomfort.
C  Monitor the patient for increased action of the anticoagulant.
D  Monitor the patient for decreased action of the anticoagulant.
Question #16
A  Local thrombosis from a peripheral intravenous line
B  Severe chest pain for the past 2 hours
C  Peptic ulcer disease
D  Gastrointestinal bleed
Question #17
A  Monitor the patient and check the therapeutic range.
B  Increase the dose of heparin.
C  Notify the health care provider immediately.
D  Stop the medication.
Question #18
A  Outside the expected target therapeutic level of anticoagulation; it is too low
B  Within the expected target therapeutic level of anticoagulation
C  Cannot be interpreted without knowing the prothrombin time and international normalized ratio
D  Outside the expected target therapeutic level of anticoagulation; it is too high
Question #19
A  Platelet count: 100,000/mm3
B  Hemoglobin level: 11 g/dL
C  Prothrombin time: 13 sec
D  Leukocyte count: 3000 cells/mm3
Question #20
A  Peptic ulcer disease, Chronic kidney disease
B  Atrial fibrillation, History of myocardial infarction
C  Chronic obstructive pulmonary disease, Atrial fibrillation
D  History of myocardial infarction, Chronic obstructive pulmonary disease
Question #21
A  Potassium level of 3.5 mEq/L
B  Platelet count of 95,000/mm3
C  International normalized ratio (INR) of 1
D  Activated partial thromboplastin time (aPTT) of 37 seconds
Question #22
A  Within the expected target therapeutic level of anticoagulation
B  The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
C  Outside the expected target therapeutic level of anticoagulation; it is too high
D  Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A  “Discard the drug within 21 days of opening the original container.”
B  “Remove from the original package and place in aluminum foil.”
C  “Refrigerate and keep away from direct sunlight.”
D  “Store the drug with the desiccant-drying agent in the packing cap.”
Question #25
A  Monitor the patient’s laboratory values correctly.
B  Teach the patient about dietary restrictions while on the medication.
C  Ensure that a loading dose was initially administered when beginning
D  Have protamine sulfate readily available at all times.
Question #26
A  Stop the intravenous (IV) drip.
B  Administer vitamin K1 (phytonadione) IV.
C  Wait for the INR to decrease.
D  Administer protamine sulfate IV.
Question #27
A  Dissolution of the clot that caused the heart attack
B  Reversal of damage from the infarction
C  Prevention of new clots from forming
D  A quick decrease in pain
Question #28
A  “I should refrain from eating broccoli during the therapy.”
B  “I should not use any acetaminophen during the therapy.”
C  “I should take oral contraceptives during the therapy.”
D  “I should follow a low-cholesterol diet during the therapy.”
Question #29
A  “I should use a soft toothbrush for dental hygiene.”
B  “I will double my dose if I forget to take it the day before.”
C  “I should keep taking ibuprofen for my arthritis.”
D  “I should decrease the dose if I start bruising easily.”
Question #30
A  “There is no real difference; dalteparin is interchangeable with regular heparin.”
B  “The only difference is that regular heparin dosing is based on the patient’s weight.”
C  “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
D  “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
Question #31
A  Utilize the Z-track method to inject the medication.
B  Rub the administration site after injecting.
C  Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
D  Administer the medication into subcutaneous tissue of the abdomen.
Question #32
A  “I will avoid contact sports.”
B  “I will contact my health care provider if I develop excessive bruising.”
C  “I will increase dark green leafy vegetables in my diet.”
D  “I will take my medication at the same time each day.”
Question #34
A  Warfarin daily
B  Vitamin K daily
C  Aspirin daily (i.e., 81 mg)
D  Recombinant factors
Question #35
A  Transient ischemic attack
B  Acute unstable angina
C  Peripheral vascular disease
D  Vitamin K deficiency
Question #36
A  Heparin subcutaneously
B  Warfarin orally
C  Enoxaparin intramuscularly
D  Dabigatran orally
Question #37
A  Over-the-counter medications
B  Urine culture
C  Ingestion of acetaminophen
D  Platelet level
Question #40
A  Blood urea nitrogen (BUN) level of 12 mg/dL
B  Platelet count of 150,000 mm3
C  Activated partial thromboplastin time (aPTT) of 120 seconds
D  International normalized ratio (INR) of 1.0
Question #41
A  Fasting blood glucose level of 95 mg/dL
B  Platelet count of 75,000 cell/μL
C  Creatinine clearance value of 40 mL/min
D  Hemoglobin level of 16.5 g/dL
Question #42
A  Thrombin
B  Antithrombin III
C  Vitamin K
D  Factor Xa
Question #43
A  Aminocaproic acid
B  Tranexamic acid
C  Alteplase
D  Desmopressin
Question #44
A  Anticoagulant
B  Antiplatelet
C  Thrombolytic
D  Antifibrinolytic
Question #45
A  Coronary artery disease
B  Cardiomyopathy
C  Heart failure
D  Acute myocardial infarction
Question #47
A  Enoxaparin
B  Argatroban
C  Fondaparinux
D  Dabigatran
Question #48
A  Warfarin
B  Direct thrombin inhibitors
C  Selective factor Xa inhibitors
D  Heparins
Question #49
A  Anticoagulants dissolve clots.
B  Anticoagulants interfere with drug metabolism.
C  Anticoagulants alter platelet function.
D  Anticoagulants prevent clots from forming.
Question #50
A  Anticoagulant
B  Antifibrinolytic
C  Thrombolytic
D  Antiplatelet
Question #51
A  Anxiety
B  Embolus to the lungs
C  Fatigue from walking with pain
D  Medication reaction
Question #52
A  Administering protamine sulfate
B  Infusing 50 mL of warfarin sodium
C  Administering vitamin K1
D  Increasing the dose of enoxaparin